Trial intelligence / Profile preview

MK-0954A in Japanese Patients with Essential Hypertension

NCT01307046Phase 3Completed

Sponsor
Organon & Co.
Start
Mar 2011
Primary completion
Feb 2012
Modality
Small Molecules
01

Overview

A Phase 3 trial of losartan + hydrochlorothiazide in essential hypertension, sponsored by Organon & Co.. Started Mar 2011; status: completed.

02

Drugs

losartan + hydrochlorothiazide
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT01307046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01307046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call